Moreover, recombinant IL-37 enhances vascular endothelial function by increasing the bioavailability of nitric oxide, and improves systemic insulin sensitivity and glucose tolerance, effects that can potentially prevent atherosclerosis development [201]. This evidence concerns the gene IL37 and atherosclerosis.